Pregled bibliografske jedinice broj: 1166622
The safety and efficacy of robot-assisted stereotactic biopsy for brain glioma: Earliest institutional experiences and evaluation of literature
The safety and efficacy of robot-assisted stereotactic biopsy for brain glioma: Earliest institutional experiences and evaluation of literature // Acta clinica Croatica, 60 (2021), 2; 296-303 doi:10.20471/acc.2021.60.02.17 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1166622 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The safety and efficacy of robot-assisted stereotactic biopsy for brain glioma: Earliest
institutional experiences and evaluation of literature
(The safety and efficacy of robot-assisted stereotactic biopsy for brain glioma: Earliest institutional experiences and
evaluation of literature)
Autori
Rotim, Krešimir ; Splavski, Bruno ; Vrban, Filip
Izvornik
Acta clinica Croatica (0353-9466) 60
(2021), 2;
296-303
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
brain glioma ; neurosurgery ; robotics ; stereotactic biopsy
Sažetak
Robot-assisted brain tumor biopsy is becoming one of the most important innova-tive technologies in neurosurgical practice. The idea behind its engagement is to advance the safety and efficacy of the biopsy procedure, which is much in demand when planning the management of endocranial tumor pathology. Herein, we provide our earliest institutional experiences in utilizing this mesmerizing technology. Cranial robotic device was employed for stereotactic robot-assisted brain glioma biopsy in three consecutive patients from our series: an anaplastic isocitrate dehydrogenase (IDH) negative astrocytoma (WHO grade III) located in the right trigone region of the periventricular white matter ; a low grade diffuse astrocytoma (WHO grade II) of bilateral thalamic region spreading into the right mesencephalic area ; and an IDH- wildtype glioblastoma (WHO grade IV) of the right frontal lobe producing a contralateral midline shifting. Robot-assisted tumor biopsy was successfully performed to get tissue samples for histopathologic and immunohistochemical analysis. The adjacent tissue iatrogenic damage of the eloquent cortical areas was minimal, while the immediate postoperative recovery was satisfactory in all patients. In conclusion, considering the preliminary results of our early experiences, robot-assisted tumor biopsy was proven to be a feasible and accurate procedure when surgery for brain glioma was not an option. It may increase safety and precision, without expanding surgical time, being similarly effective when compared to standard stereotactic and manual biopsy. Using this method to provide accurate sampling for histopathologic and immunohis-tochemical analysis is a safe and easy way to determine management strategies and outcome of different types of brain glioma.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Zdravstveno veleučilište, Zagreb,
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE